Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

A novel therapeutic strategy for adolescent idiopathic scoliosis based on osteoporotic concept.

Lu L, Dai Z, Lv G, Kang Y, Jiang Y.

Med Hypotheses. 2013 Jun;80(6):773-5. doi: 10.1016/j.mehy.2013.03.008. Epub 2013 Apr 4.

PMID:
23562283
2.

Association between osteoprotegerin gene polymorphism and bone mineral density in patients with adolescent idiopathic scoliosis.

Eun IS, Park WW, Suh KT, Kim JI, Lee JS.

Eur Spine J. 2009 Dec;18(12):1936-40. doi: 10.1007/s00586-009-1145-z. Epub 2009 Aug 25.

3.

Increased expression of receptor activator of nuclear factor-κB ligand in osteoblasts from adolescent idiopathic scoliosis patients with low bone mineral density.

Zhou S, Wang W, Zhu Z, Sun X, Zhu F, Yu Y, Qian B, Wang B, Yin G, Qiu Y.

J Huazhong Univ Sci Technolog Med Sci. 2012 Oct;32(5):686-90. doi: 10.1007/s11596-012-1018-2. Epub 2012 Oct 18.

PMID:
23073797
4.

Osteopenia predicts curve progression of adolescent idiopathic scoliosis in girls treated with brace treatment.

Sun X, Wu T, Liu Z, Zhu Z, Qian B, Zhu F, Ma W, Yu Y, Wang B, Qiu Y.

J Pediatr Orthop. 2013 Jun;33(4):366-71. doi: 10.1097/BPO.0b013e31827b7b5f.

PMID:
23653023
5.

The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.

Kiechl S, Werner P, Knoflach M, Furtner M, Willeit J, Schett G.

Expert Rev Cardiovasc Ther. 2006 Nov;4(6):801-11. Review.

PMID:
17173497
7.
8.

The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease.

D'Amelio P, Isaia G, Isaia GC.

J Endocrinol Invest. 2009;32(4 Suppl):6-9. Review.

PMID:
19724159
9.

Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss.

Trouvin AP, Goëb V.

Clin Interv Aging. 2010 Nov 19;5:345-54. doi: 10.2147/CIA.S10153. Review.

10.

Clinical potential of RANKL inhibition for the management of postmenopausal osteoporosis and other metabolic bone diseases.

Delmas PD.

J Clin Densitom. 2008 Apr-Jun;11(2):325-38. doi: 10.1016/j.jocd.2008.02.002. Epub 2008 Apr 2. Review.

PMID:
18375161
11.

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases.

Baud'huin M, Lamoureux F, Duplomb L, Rédini F, Heymann D.

Cell Mol Life Sci. 2007 Sep;64(18):2334-50. Review.

PMID:
17530461
12.

The clinical significance of OPG/sRANKL ratio in thalassemia patients suffering from osteopenia or osteoporosis in Egyptian patients.

Salah H, Atfy M, Fathy A, Atfy M, Mansor H, Saeed J.

Immunol Invest. 2010;39(8):820-32. doi: 10.3109/08820139.2010.498492. Epub 2010 Aug 18.

PMID:
20718662
13.

Theoretical investigation of the role of the RANK-RANKL-OPG system in bone remodeling.

Pivonka P, Zimak J, Smith DW, Gardiner BS, Dunstan CR, Sims NA, Martin TJ, Mundy GR.

J Theor Biol. 2010 Jan 21;262(2):306-16. doi: 10.1016/j.jtbi.2009.09.021. Epub 2009 Sep 25.

PMID:
19782692
14.
15.

Signaling axis in osteoclast biology and therapeutic targeting in the RANKL/RANK/OPG system.

Tanaka S.

Am J Nephrol. 2007;27(5):466-78. Epub 2007 Jul 25. Review. Erratum in: Am J Nephrol. 2007;27(5):544.

PMID:
17652963
16.

[The expression of receptor activator nuclear factor-kappaB ligand and osteoprotegerin in cholesteatoma].

Ma Y, Ye S.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 Apr;22(7):293-5. Chinese.

PMID:
18589796
17.

[Expression and significance of nuclear factor-kappa B ligand and correlation factor in the tissue of otitis media with cholesteatoma].

Xia M, Ding S, Zhang H, Liu F, Yin H, Xu A.

Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2007 Apr;21(7):315-7. Chinese.

PMID:
17580719
18.

Decreased circulating leptin level and its association with body and bone mass in girls with adolescent idiopathic scoliosis.

Qiu Y, Sun X, Qiu X, Li W, Zhu Z, Zhu F, Wang B, Yu Y, Qian B.

Spine (Phila Pa 1976). 2007 Nov 15;32(24):2703-10.

PMID:
18007248
19.

OPG, RANK and RANK ligand expression in thyroid lesions.

Heymann MF, Riet A, Le Goff B, Battaglia S, Paineau J, Heymann D.

Regul Pept. 2008 Jun 5;148(1-3):46-53. doi: 10.1016/j.regpep.2008.02.004. Epub 2008 Feb 19.

PMID:
18367263
20.

Supplemental Content

Support Center